Key Market Indicator:
F&G: 52
25.094,71 NASDAQ · 48.877,01 DOW · 6.839,75 S&P · 4.752,66 Gold · 64,16 BRENT

One Community. One Spirit. N#1 Broker.
all asset classes · all possibilities

Switch View
Hedge the Peak | Protect your Profits
© Globe Newswire
18.02.2025
ISIN: SE0002190926
Karolinska Development AB
KDEV
LISTED
STO
Karolinska Developments portfolio company Promimic publishes positive results on reduction of bacteria growth on HAnano Surface
Article
News Preview
STOCKHOLM, SWEDEN, February 18 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company Promimic has published positive results showing a reduction of bacterial growth on the company’s implant surface HAnano Surface. The results are published in the Journal of Functional Biomaterials....
Themefolio
Profiler
Peergroup
© PR Newswire
18.02.2025
ISIN: SE0010323311
BioArctic AB
BIOA B
LISTED
STO
Leqembi® sales reaches €200 million - first sales milestone achieved
Article
News Preview
STOCKHOLM, Feb. 18, 2025 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai has notified BioArctic that the first sales milestone according to the licensing agreement has been reached. The milestone was reached as sales of Leqembi reached €200 million in Eisai fiscal year 2024 (April 2024 - Match 2025). The event entit...
Themefolio
Profiler
Peergroup
© PR Newswire
18.02.2025
ISIN: SE0010323311
BioArctic AB
BIOA B
LISTED
STO
Leqembi® sales reaches €200 million - first sales milestone achieved
Article
News Preview
STOCKHOLM, Feb. 18, 2025 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai has notified BioArctic that the first sales milestone according to the licensing agreement has been reached. The milestone was reached as sales of Leqembi reached €200 million in Eisai fiscal year 2024 (April 2024 - Match 2025). The event entit...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
More Info
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© Globe Newswire
17.02.2025
ISIN: BE0003818359
Galapagos NV
GLPG
LISTED
EURONEXT
Galapagos receives transparency notification and 13D filing from Tang Capital
Article
News Preview
Mechelen, Belgium; February 17, 2025, 22:01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) received a transparency notification and 13D filing from Tang Capital. ...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© Globe Newswire
17.02.2025
ISIN: FI0009014377
Orion Oyj
ORNBV
LISTED
HEL
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
Article
News Preview
ORION CORPORATION STOCK EXCHANGE RELEASE – MAJOR SHAREHOLDER ANNOUNCEMENTS17 FEBRUARY 2025 at 15.15 EET...
Themefolio
Profiler
Peergroup
© BusinessWire
17.02.2025
ISIN: IE0005711209
ICON PLC
ICLR
LISTED
NASDAQ
ICLR INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against ICON PLC and Announces Opportunity for Investors with Substantial Losses to Lead Class Action Lawsuit
Article
News Preview
Robbins Geller Rudman & Dowd LLP announces that purchasers of ICON PLC (NASDAQ: ICLR) ordinary shares between July 27, 2023 and October 23, 2024, both dates inclusive (the “Class Period”), have until April 11, 2025 to seek appointment as lead plaintiff of the ICON class action lawsuit. Captioned Shing v. ICON plc, No. 25-cv-00763 (E.D.N.Y.), t...
Themefolio
Profiler
Peergroup
© EQS Newswire
17.02.2025
ISIN: FR0013154002
Sartorius Stedim Biotech SA
DIM
LISTED
EURONEXT
Sartorius Stedim Biotech releases Universal Registration Document 2024
Article
News Preview
Sartorius Stedim Biotech SA / Key word(s): Annual Results Sartorius Stedim Biotech releases Universal Registration Document 2024 17-Feb-2025 / 10:02 CET/CEST Aubagne, France | February 17, 2025 Sartorius Stedim Biotech releases Universal Registration Document 2024Sartorius Stedim Biotech, a leading partner of the biopharma ind......
Themefolio
Profiler
Peergroup
© EQS Newswire
17.02.2025
ISIN: DE0007165631
Sartorius AG
SRT3
LISTED
XETR
Sartorius releases Annual Report for 2024
Article
News Preview
Göttingen, Germany | February 17, 2025   Sartorius releases Annual Report for 2024   The life science group Sartorius today released its Annual Report for 2024. The document is available at the following link: https://ir-reports.sartorius.com/en/ag/fy-2024/       Financial calendar March 27, 2025         Annual Shareholders’ Meeting April 16, 2025......
Themefolio
Profiler
Peergroup
© EQS Newswire
17.02.2025
ISIN: DE0007165631
Sartorius AG
SRT3
LISTED
XETR
Sartorius veröffentlicht Geschäftsbericht für 2024
Article
News Preview
Göttingen, 17. Februar 2025   Sartorius veröffentlicht Geschäftsbericht für 2024   Der Life-Science-Konzern Sartorius hat heute seinen Geschäftsbericht für 2024 veröffentlicht. Das Dokument ist unter folgendem Link verfügbar: https://ir-reports.sartorius.com/de/ag/fy-2024/       Nächste Termine   27. März 2025            Hauptversammlung   16. Apri......
Themefolio
Profiler
Peergroup
© EQS Newswire
17.02.2025
ISIN: DE000A1EWVY8
Formycon AG
FYB
LISTED
XETR
Formycon AG informs about recent developments in various biosimilar projects and invites to conference call
Article
News Preview
Press Release // February 17, 2025 Formycon AG informs about recent developments in various biosimilar projects and invites to conference call   Formycon continues FYB206 development without Phase III trial and thus takes pioneering role among pembrolizumab biosimilar developers; investment savings expected to amount to a high double-digit millio......
Themefolio
Profiler
Peergroup
© EQS Newswire
17.02.2025
ISIN: DE000A1EWVY8
Formycon AG
FYB
LISTED
XETR
Formycon AG informiert über jüngste Entwicklungen in verschiedenen Biosimilar-Projekten und lädt zur Telefonkonferenz ein
Article
News Preview
Pressemitteilung // 17. Februar 2025  Formycon AG informiert über jüngste Entwicklungen in verschiedenen Biosimilar-Projekten und lädt zur Telefonkonferenz ein Formycon setzt FYB206-Entwicklung ohne Phase-III-Studie fort und nimmt damit Vorreiterrolle unter Pembrolizumab-Biosimilar-Entwicklern ein; Investitionsersparnisse belaufen sich voraussic......
Themefolio
Profiler
Peergroup
© EQS Newswire
17.02.2025
ISIN: DE000A1EWVY8
Formycon AG
FYB
LISTED
XETR
Formycon announces decision on Phase III trial with FYB206 and provides update on potential need to adjust the valuation of FYB202 and FYB201
Article
News Preview
Disclosure of inside information according to Article 17 of the Regulation (EU) No 596/2014 Formycon announces decision on Phase III trial with FYB206 and provides update on potential need to adjust the valuation of FYB202 and FYB201 Formycon terminates Phase III study ("Lotus") for FYB206 following positive feedback from the U.S. Food and Drug A......
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© EQS Newswire
17.02.2025
ISIN: DE000A1EWVY8
Formycon AG
FYB
LISTED
XETR
Formycon gibt Entscheidung zu Phase-III-Studie von FYB206 bekannt und informiert über potenziellen Anpassungsbedarf bei der Bewertung von FYB202 und FYB201
Article
News Preview
Veröffentlichung von Insiderinformationen nach Artikel 17 der Verordnung (EU) Nr. 596/2014 Formycon gibt Entscheidung zu Phase-III-Studie von FYB206 bekannt und informiert über potenziellen Anpassungsbedarf bei der Bewertung von FYB202 und FYB201 Formycon stellt Phase-III-Studie (Lotus) für FYB206 nach positivem Feedback der U.S. Food and Drug Ad......
Themefolio
Profiler
Peergroup
© Globe Newswire
17.02.2025
ISIN: DK0010272632
GN Store Nord A/S
GN
LISTED
CPH
GN Store Nord A/S - Notice to convene the Annual General Meeting 2025
Article
News Preview
GN Store Nord’s Annual General Meeting will be held on Wednesday, March 12, 2025, at 10:00 a.m. CET at the company’s address: Lautrupbjerg 7, 2750 Ballerup, Denmark....
Themefolio
Profiler
Peergroup
© Globe Newswire
16.02.2025
ISIN: GB0009223206
Smith & Nephew PLC
SN
LISTED
LSE
Smith+Nephew steps forward with innovative Sports Medicine foot & ankle repair solutions in Australia and New Zealand
Article
News Preview
First in market to offer Adjustable Tensioning Technology* for insertional Achilles reconstruction and lateral ankle instability repair...
Themefolio
Profiler
Peergroup
© BusinessWire
16.02.2025
ISIN: IE0005711209
ICON PLC
ICLR
LISTED
NASDAQ
ICLR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that ICON PLC Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Article
News Preview
Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against ICON PLC (“ICON” or “the Company”) (NASDAQ: ICLR) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of...
Themefolio
Profiler
Peergroup
© Globe Newswire
14.02.2025
ISIN: DK0015998017
Bavarian Nordic A/S
BAVA
LISTED
CPH
Bavarian Nordic Receives U.S. FDA Approval of Chikungunya Vaccine for Persons Aged 12 and Older
Article
News Preview
COPENHAGEN, Denmark, February 14, 2025 – Bavarian Nordic A/S (OMX: BAVA) announced today that the U.S. Food and Drug Administration (FDA) has approved VIMKUNYA™ (Chikungunya Vaccine, Recombinant) for injection, the first virus-like particle (VLP) single-dose chikungunya vaccine in the U.S. for persons 12 years of age and older....
Themefolio
Profiler
Peergroup
© Globe Newswire
14.02.2025
ISIN: FR0004163111
Genfit SA
GNFT
LISTED
EURONEXT
GENFIT Announces the Amendment of the Final Terms of the Dual Proposal to the 2025 OCEANEs Holders
Article
News Preview
Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), February 14, 2025 - GENFIT (Nasdaq and Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today announced the amendment of the final terms of the 2025 OCEANEs repurchase proposal and t...
Themefolio
Profiler
Peergroup
© BusinessWire
14.02.2025
ISIN: IE0005711209
ICON PLC
ICLR
LISTED
NASDAQ
Kessler Topaz Meltzer & Check, LLP Class Action Announcement ICLR: A Securities Fraud Class Action Lawsuit Was Filed Against ICON Public Limited Company (ICLR)
Article
News Preview
The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against ICON Public Limited Company (“ICON”) (NASDAQ: ICLR) on behalf of all purchasers of ICON ordinary shares between July 27, 2023 and October 23, 2024, inclusive (the “Class Period”). The lead plaintiff...
Themefolio
Profiler
Peergroup
© ActuNews
14.02.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
Oxurion versterkt zijn Raad van Bestuur met de komst van Nelly Souleymane
Article
News Preview
LEUVEN, BELGIË - 14 februari 2024 – 19u00 CET - Oxurion NV (Euronext Brussels: OXUR), een biofarmaceutisch bedrijf met hoofdzetel in Leuven, kondigt een wijziging aan in haar Raad van Bestuur met het vertrek van mevrouw Anat Loewenstein en mevrouw Nathalie Laarakker, met ingang vanaf 13 januari 2025, en de cooptatie door de Raad van...
Themefolio
Profiler
Peergroup
© ActuNews
14.02.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
Oxurion renforce son Conseil d'Administration avec l'arrivée de Nelly Souleymane
Article
News Preview
Louvain, BELGIQUE – 14 février 2024 – 19h00, Oxurion NV (Euronext Bruxelles : OXUR), entreprise biopharmaceutique basée à Louvain, annonce une évolution de son Conseil d'Administration avec le départ de Mme Anat Loewenstein et Mme Nathalie Laarakker, effectif depuis le 13 janvier 2025, et l'int...
Themefolio
Profiler
Peergroup
© ActuNews
14.02.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
Oxurion strengthens its Board of Directors with the arrival of Nelly Souleymane
Article
News Preview
LEUVEN, BELGIUM - February 14, 2024 - 7:00PM, Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, announces a change in its Board of Directors with the departure of Ms. Anat Loewenstein and Ms. Nathalie Laarakker, effective as of January 13, 2025, and the integration of Nelly Souleymane as an indepen...
Themefolio
Profiler
Peergroup
© BusinessWire
14.02.2025
ISIN: IE0005711209
ICON PLC
ICLR
LISTED
NASDAQ
Deadline Alert: ICON plc (ICLR) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
Article
News Preview
Glancy Prongay & Murray LLP reminds investors of the upcoming April 11, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired ICON plc (“ICON” or the “Company”) (NASDAQ: ICLR) ordinary shares between July 27, 2023 and October 23, 2024, inclusive (the “Class Period”)....
Themefolio
Profiler
Peergroup
© PR Newswire
14.02.2025
ISIN: SE0000135485
RaySearch Laboratories AB (publ)
RAY B
LISTED
STO
Invitation to presentation of RaySearch's Year-end report 2024
Article
News Preview
STOCKHOLM, Feb. 14, 2025 /PRNewswire/ -- Analysts, investors, and the media are invited to a presentation of RaySearch's Year-end report 2024 on February 21, 2025, at 10.00 am CET. The report will be published on February 21, 2025, at 07.45 am and will be available together with presentation slides on raysearchlabs.com. Johan Löf, founder and CEO...
Themefolio
Profiler
Peergroup
© Globe Newswire
14.02.2025
ISIN: FI0009014377
Orion Oyj
ORNBV
LISTED
HEL
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
Article
News Preview
ORION CORPORATION STOCK EXCHANGE RELEASE – MAJOR SHAREHOLDER ANNOUNCEMENTS14 FEBRUARY 2025 at 16.15 EET...
Themefolio
Profiler
Peergroup
© Globe Newswire
14.02.2025
ISIN: ES0167733015
Oryzon Genomics SA
ORY
LISTED
BME
ORYZON Announces Journal Publication of Final Phase IIa REIMAGINE Results with Vafidemstat in Psychiatry and Clinical Neurosciences
Article
News Preview
MADRID and CAMBRIDGE, Mass., Feb. 14, 2025 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announced today that the final results of the Phase IIa REIMAGINE study, which evaluated the safety...
Themefolio
Profiler
Peergroup
© PR Newswire
14.02.2025
ISIN: IE0005711209
ICON PLC
ICLR
LISTED
NASDAQ
Contact Levi & Korsinsky by April 11, 2025 Deadline to Join Class Action Against ICON Public Limited Company(ICLR)
Article
News Preview
NEW YORK, Feb. 14, 2025 /PRNewswire/ --  Levi & Korsinsky, LLP notifies investors in ICON Public Limited Company ("ICON " or the "Company") (NASDAQ: ICLR) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seek...
Themefolio
Profiler
Peergroup
© Globe Newswire
14.02.2025
ISIN: DK0010272632
GN Store Nord A/S
GN
LISTED
CPH
New share-based incentive program for members of management and certain key employees
Article
News Preview
With reference to GN's Remuneration Policy which was approved at the annual general meeting on March 13, 2024 and pursuant to which the long-term incentive program from 2025 onward will be based on performance share units (PSUs) to support performance, retention, and alignment of interest with the company’s shareholders, the Board of Directors of G...
Themefolio
Profiler
Peergroup
© BusinessWire
13.02.2025
ISIN: US29332G1022
Enhabit Inc
EHAB
LISTED
NYSE
Enhabit Home Health & Hospice Announces Date of 2024 Fourth Quarter Earnings Call
Article
News Preview
Enhabit, Inc. (NYSE: EHAB), a leading national home health and hospice provider, today announced it will report its results for the fourth quarter ended Dec. 31, 2024, on March 5, 2025, and host a webcast and conference call on March 6, 2025. Individuals who would like to participate in the conference call webcast should join 15 minutes before the...
Themefolio
Profiler
Peergroup
© BusinessWire
13.02.2025
ISIN: NL0012169213
Qiagen NV
QGEN
LISTED
NYSE
QIAGEN Strengthens Global Bioinformatics Leadership With New Data Center in Australia/Asia-Pacific Region
Article
News Preview
QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the official opening of a new data center in Melbourne, Australia, designed to strengthen its global bioinformatics leadership position in this region of the world. This latest addition reflects QIAGEN’s ongoing commitment to enhance its bioinformatics data infrastructure, enabli...
Themefolio
Profiler
Peergroup
© BusinessWire
13.02.2025
ISIN: IE0005711209
ICON PLC
ICLR
LISTED
NASDAQ
Deadline Approaching: ICON plc (ICLR) Investors Who Lost Money Urged To Contact Law Offices of Howard G. Smith
Article
News Preview
Law Offices of Howard G. Smith reminds investors of the upcoming April 11, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased ICON plc (“ICON” or the “Company”) (NASDAQ: ICLR) ordinary shares between July 27, 2023 and October 23, 2024, inclusive (the “Class Period”). IF YOU ARE AN INVESTOR WHO SU...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.02.2025
ISIN: DK0060257814
Zealand Pharma A/S
ZEAL
LISTED
CPH
Zealand Pharma conference call on February 20 at 2pm CET (8am ET) to present full year 2024 financial results
Article
News Preview
Press Release – No. 3 / 2025...
Themefolio
Profiler
Peergroup
© BusinessWire
13.02.2025
ISIN: IE0005711209
ICON PLC
ICLR
LISTED
NASDAQ
ICON INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against ICON PLC and Announces Opportunity for Investors with Substantial Losses to Lead Class Action Lawsuit
Article
News Preview
The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers of ICON PLC (NASDAQ: ICLR) ordinary shares between July 27, 2023 and October 23, 2024, both dates inclusive (the “Class Period”), have until April 11, 2025 to seek appointment as lead plaintiff of the ICON class action lawsuit. Captioned Shing v. ICON plc, No. 25-cv-007...
Themefolio
Profiler
Peergroup
© BusinessWire
13.02.2025
ISIN: US88023B1035
Tempus AI, Inc.
TEM
LISTED
NASDAQ
Tempus Announces Collaboration with IFLI Aimed at Supporting Development of Targeted Therapies for Follicular Lymphoma
Article
News Preview
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced a new collaboration with the Institute for Follicular Lymphoma Innovation (IFLI), a global, non-profit, private foundation dedicated to accelerating the development of innovative treatment options for patie...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.02.2025
ISIN: DK0010272202
Genmab A/S
GMAB
LISTED
CPH
Notice to Convene the Annual General Meeting of Genmab A/S
Article
News Preview
Company Announcement...
Themefolio
Profiler
Peergroup
© EQS Newswire
13.02.2025
ISIN: DE0005659700
Eckert & Ziegler SE
EUZ
LISTED
XETR
Eckert & Ziegler Affected by Cyber Attack 
Article
News Preview
Berlin, 13 February 2025. Eckert & Ziegler SE (ISIN DE0005659700, TecDAX) has suffered a cyber attack on parts of its IT systems. The systems were temporarily shut down proactively and disconnected from the internet to minimise any potential impact. The IT systems and the effects of the attack are currently being examined. The utmost care is be......
Themefolio
Profiler
Peergroup
© EQS Newswire
13.02.2025
ISIN: DE0005659700
Eckert & Ziegler SE
EUZ
LISTED
XETR
Eckert & Ziegler von Cyberangriff betroffen 
Article
News Preview
Berlin, 13. Februar 2025. Bei der Eckert & Ziegler SE (ISIN DE0005659700, TecDAX) hat es einen Cyberangriff auf Teile ihrer IT-Systeme gegeben. Die Systeme wurden vorübergehend proaktiv heruntergefahren und vom Internet getrennt, um potenzielle Auswirkungen zu minimieren. Die IT-Systeme sowie die Auswirkungen des Angriffs werden aktuell geprüft......
Themefolio
Profiler
Peergroup
© EQS Newswire
13.02.2025
ISIN: DE000A3ENQ51
SCHOTT Pharma AG & Co KgaA
1SXP
LISTED
XETR
SCHOTT Pharma records good start into fiscal year and confirms full year outlook
Article
News Preview
SCHOTT Pharma records good start into fiscal year and confirms full year outlook Q1 2025 revenues reached EUR 230m; decrease of 1% yoy as reported or increase of 4% at constant currencies Q1 2025 EBITDA margin of 25.1% as reported or 26.3% at constant currencies Share of strong-margin high-value solutions (HVS) further increased to 55% Busines......
Themefolio
Profiler
Peergroup
© EQS Newswire
13.02.2025
ISIN: DE000A3ENQ51
SCHOTT Pharma AG & Co KgaA
1SXP
LISTED
XETR
SCHOTT Pharma startet gut ins neue Geschäftsjahr und bestätigt Prognose für 2025
Article
News Preview
SCHOTT Pharma startet gut ins neue Geschäftsjahr und bestätigt Prognose für 2025 Q1 2025: Umsatz von 230 Mio. Euro; berichteter Rückgang von 1 %, währungsbereinigtes Umsatzwachstum von 4 % gegenüber dem Vorjahr Q1 2025: EBITDA-Marge von 25,1 % berichtet, und 26,3 % währungsbereinigt Anteil der margenstarken High-Value-Lösungen (HVS) weiter auf ......
Themefolio
Profiler
Peergroup
© Globe Newswire
13.02.2025
ISIN: NL0015000DX5
Atai Life Sciences N.V.
ATAI
LISTED
NASDAQ
atai Life Sciences Announces Pricing of Public Offering of Common Shares
Article
News Preview
NEW YORK and BERLIN, Feb. 12, 2025 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai” or “Company”), a clinical-stage biopharmaceutical company focused on transforming the treatment of mental health disorders, today announced the pricing of a registered underwritten offering of 26,190,477 common shares, at a price of $2.10 per share. a...
Themefolio
Profiler
Peergroup
© BusinessWire
12.02.2025
ISIN: IE0005711209
ICON PLC
ICLR
LISTED
NASDAQ
Law Offices of Frank R. Cruz Encourages ICON plc (ICLR) Investors To Inquire About Securities Fraud Class Action
Article
News Preview
The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of investors who purchased ICON plc (“ICON” or the “Company”) (NASDAQ: ICLR) ordinary shares between July 27, 2023 and October 23, 2024, inclusive (the “Class Period”). ICON investors have until April 11, 2025 to file a lead plaintiff motion. IF YOU S...
Themefolio
Profiler
Peergroup
© Globe Newswire
12.02.2025
ISIN: US04351P1012
Ascendis Pharma A/S
ASND
LISTED
NASDAQ
Ascendis Pharma Reports Fourth Quarter and Full Year 2024 Financial Results
Article
News Preview
– Strong early U.S. YORVIPATH® launch with 908 prescriptions as of Feb. 7, 2025; YORVIPATH full year 2024 revenue of €28.7 million...
Themefolio
Profiler
Peergroup
© Globe Newswire
12.02.2025
ISIN: FI0009014377
Orion Oyj
ORNBV
LISTED
HEL
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
Article
News Preview
ORION CORPORATION STOCK EXCHANGE RELEASE – MAJOR SHAREHOLDER ANNOUNCEMENTS12 FEBRUARY 2025 at 21.00 EET ...
Themefolio
Profiler
Peergroup
© BusinessWire
12.02.2025
ISIN: IE0005711209
ICON PLC
ICLR
LISTED
NASDAQ
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Encourages ICON plc (ICLR) Investors to Inquire About Securities Fraud Class Action
Article
News Preview
Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired ICON plc (“ICON” or the “Company”) (NASDAQ: ICLR) ordinary shares between July 27, 2023 and October 23, 2024, inclusive (the “Class Period”...
Themefolio
Profiler
Peergroup
© BusinessWire
12.02.2025
ISIN: IE0005711209
ICON PLC
ICLR
LISTED
NASDAQ
ICLR Investors Have Opportunity to Lead ICON Public Limited Company Securities Fraud Lawsuit with the Schall Law Firm
Article
News Preview
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ICON Public Limited Company (“Icon” or “the Company”) (NASDAQ: ICLR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission....
Themefolio
Profiler
Peergroup
© Globe Newswire
12.02.2025
ISIN: DK0010272202
Genmab A/S
GMAB
LISTED
CPH
Genmab Files Annual Report with the U.S. Securities and Exchange Commission
Article
News Preview
Media ReleaseCOPENHAGEN, Denmark; February 12, 2025...
Themefolio
Profiler
Peergroup
© Globe Newswire
12.02.2025
ISIN: DK0010272202
Genmab A/S
GMAB
LISTED
CPH
Genmab Publishes 2024 Annual Report
Article
News Preview
Company Announcement...
Themefolio
Profiler
Peergroup
© Globe Newswire
12.02.2025
ISIN: US5588681057
Madrigal Pharmaceuticals Inc
MDGL
LISTED
NASDAQ
Madrigal Pharmaceuticals to Release Fourth-Quarter and Full-Year 2024 Financial Results and Host Webcast on February 26, 2025
Article
News Preview
CONSHOHOCKEN, Pa., Feb. 12, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) announced today that it will release its fourth-quarter and full-year 2024 financial results on Wednesday, Feb. 26, 2025, prior to the open of the U.S. financial markets....
Themefolio
Profiler
Peergroup
© PR Newswire
12.02.2025
ISIN: GB00BN4HT335
Indivior PLC
INDV
LISTED
NASDAQ
Indivior Statement RE: Delayed FDA Approval of SUBLOCADE® Label Changes
Article
News Preview
RICHMOND, Va., Feb. 12, 2025 /PRNewswire/ -- Indivior PLC (Nasdaq/LSE: INDV) provides the following update regarding its PDUFA action date for label changes (rapid initiation protocol and alternative injection sites) for SUBLOCADE® (buprenorphine extended-release) Injection, which was scheduled for February 7, 2025:...
Themefolio
Profiler
Peergroup
© Newsfile
12.02.2025
ISIN: NL0011832936
Cosmo Pharmaceuticals NV
COPN
LISTED
SIX
Cosmo to Host Investor Day on April 9, 2025
Article
News Preview
Dublin, Ireland--(Newsfile Corp. - February 12, 2025) - Cosmo Pharmaceuticals N.V. (SIX: COPN) (FSE: C43) (“Cosmo”) is pleased to announce that it will host an Investor Day on Wednesday, April 9, 2025. The live event will be held at the Hotel “Park Hyatt” at Beethovenstrasse 21 in 8002 Zurich, S...
Themefolio
Profiler
Peergroup
© EQS Newswire
12.02.2025
ISIN: DE0005313704
Carl Zeiss Meditec AG
AFX
LISTED
XETR
Carl Zeiss Meditec erzielt leichtes Umsatzwachstum im ersten Quartal 2024/25
Article
News Preview
Carl Zeiss Meditec erzielt leichtes Umsatzwachstum im ersten Quartal 2024/25  Auftragseingang und Auftragsbestand deutlich erholt   JENA, 12. Februar 2025 Carl Zeiss Meditec erzielte im ersten Quartal des Geschäftsjahres 2024/25 aufgrund der DORC-Akquisition einen Umsatz von rund 490,5 Millionen Euro (Vj. 475,0 Millionen Euro), ein Wachstum v......
Themefolio
Profiler
Peergroup
© EQS Newswire
12.02.2025
ISIN: DE0005313704
Carl Zeiss Meditec AG
AFX
LISTED
XETR
Carl Zeiss Meditec achieves slight revenue growth in first three months of 2024/25
Article
News Preview
Carl Zeiss Meditec achieves slight revenue growth in first three months of 2024/25  Significant recovery in order entry and order backlog   JENA, 12 February 2025 Carl Zeiss Meditec generated revenue of €490.5m in the first three months of fiscal year 2024/25 (prior year: €475.0m), corresponding to growth of +3.2% (adjusted for currency effec......
Themefolio
Profiler
Peergroup
© BusinessWire
12.02.2025
ISIN: IE0005711209
ICON PLC
ICLR
LISTED
NASDAQ
Law Offices of Howard G. Smith Encourages ICON plc (ICLR) Investors To Inquire About Securities Fraud Class Action
Article
News Preview
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased ICON plc (“ICON” or the “Company”) (NASDAQ: ICLR) ordinary shares between July 27, 2023 and October 23, 2024, inclusive (the “Class Period”). ICON investors have until April 11, 2025 to file a lead plaintiff motion. IF YOU ARE...
Themefolio
Profiler
Peergroup
© BusinessWire
12.02.2025
ISIN: IE0005711209
ICON PLC
ICLR
LISTED
NASDAQ
ICON SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against ICON plc - ICLR
Article
News Preview
Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until April 11, 2025 to file lead plaintiff applications in a securities class action lawsuit against ICON plc (the “Company”) (NasdaqGS: ICLR), if they purchased the Company’s shares between July 27, 2023...
Themefolio
Profiler
Peergroup
© BusinessWire
11.02.2025
ISIN: IE0005711209
ICON PLC
ICLR
LISTED
NASDAQ
Rosen Law Firm Urges ICON plc (NASDAQ: ICLR) Stockholders to Contact the Firm for Information About Their Rights
Article
News Preview
Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of purchasers of ordinary shares of ICON plc (NASDAQ: ICLR) between July 27, 2023 and October 23, 2024, inclusive (the “Class Period”). ICON is a clinical research organization. For more information, submit a form, email attorney Philli...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.02.2025
ISIN: US0327241065
AnaptysBio Inc
ANAB
LISTED
NASDAQ
Anaptys to Announce Top-line Data from Phase 2b Trial of Rosnilimab, a PD-1 Depleter and Agonist, in Rheumatoid Arthritis on Feb. 12, 2025
Article
News Preview
SAN DIEGO, Feb. 11, 2025 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, will host an investor call and live webcast to review top-line data from the global Phase 2b RENOIR clinical trial of investigational rosnilimab, a depleter and agonist of P...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.02.2025
ISIN: BE0003766806
Ion Beam Applications SA
IBAB
LISTED
EURONEXT
IBA – Transparency Notification
Article
News Preview
 ...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.02.2025
ISIN: BE0003766806
Ion Beam Applications SA
IBAB
LISTED
EURONEXT
IBA – Transparency Notification IBA SA
Article
News Preview
 ...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.02.2025
ISIN: BE0003766806
Ion Beam Applications SA
IBAB
LISTED
EURONEXT
IBA - Information réglementée
Article
News Preview
 ...
Themefolio
Profiler
Peergroup
© BusinessWire
11.02.2025
ISIN: US88023B1035
Tempus AI, Inc.
TEM
LISTED
NASDAQ
Tempus to Report Fourth Quarter and Full Year 2024 Financial Results on February 24
Article
News Preview
Tempus AI, Inc. (NASDAQ: TEM), a leader in artificial intelligence and precision medicine, today announced they will report financial results for the fourth quarter and full year 2024 on Monday, February 24, 2025. The company will hold the earnings conference call at 4:30 p.m. ET. The company’s quarterly earnings will be released the same day. T...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
Indices
DAX, DOW, S&P, FTSE...
Realtime Trading
With & without leverage
Currencies
EUR, USD, JPY, BRL, GBP ....
50 FX-Pairs
Top Conditions, Tied spreads, Mini/Micro
Commodities
Brent, WTI, Coffee, Wheat....
Long & Short
Crude oil, Agricultural & more
Metals
Gold, Silver, Palladium, Platinum
Hedging
Soft-,Heavy-, Precious Metals
Stocks & ETF
TSLA, NFLX, NVDA, MSFT, AAPL ....
Leveraged Equity Trading
USA, Europe, Asia
More information, click here

More sector specific news

Your Press Release is missing or you want share news over GICS11? Drop us a line.

Gamechanger in online marketing · Innovation as a service · Upgrade your own internet presence.

XLB
XLE
XLU
XLY
XLF
XLP
XLV
XLK
XLC
XLI
XLRE
© 2026 Select Sector SPDRs
* * *
More Sector related Investment Ideas
XLB
XLE
XLU
XLY
XLF
XLP
XLV
XLK
XLC
XLI
XLRE
© 2026 WEBs Investments ETFs
About the newsfeed
#1
What types of information are provided on this portal - and what purpose does it serve?
The portal provides structured, stock market-relevant company information that is specifically assigned to a particular economic sector. The focus is on current announcements from official NewsWire sources, supplemented by company profiles, filter options by sector and sector-specific research aids. The aim is to offer an interested group of people a systematically structured research environment that improves their understanding of sector developments and corporate strategies.
#2
Why are companies categorized according to a certain system?
Financial markets consist of thousands of listed companies with very different business models. In order to create transparency and comparability, companies worldwide are assigned to standardized classifications. These classifications help investors to better analyze markets, identify sector-specific trends and make more targeted investment decisions.
#3
What classification standards exist for grouping companies?
There are various industry classifications that are used depending on the region or application. The best known include GICS (Global Industry Classification Standard), ICB (Industry Classification Benchmark), NAICS (North American Industry Classification System) and TRBC (Thomson Reuters Business Classification). Most institutional investors and ETFs worldwide use GICS or ICB as a benchmark.
#4
What classification standard is this financial information portal based on?
The portal uses the Global Industry Classification Standard (GICS), which was jointly developed by MSCI and S&P Dow Jones Indices. GICS is widely used in the institutional financial world and forms the basis for many global equity indices, ETFs and research systems.
#5
What exactly does GICS mean - and how is the system structured?
GICS stands for Global Industry Classification Standard. It is a hierarchical structure that divides listed companies worldwide into four levels: Sector, Industry Group, Industry Sector and Sub-Industry. In total, the system comprises 11 main sectors, over 60 industries and more than 150 sub-categories. It allows a consistent, internationally comparable analysis of economic activities.
#6
Why is GICS important in the financial world?
GICS offers a standardized language for investment decisions. It makes it possible to compare companies with similar business models - regardless of country, stock exchange or company size. Many investment funds, indices and research houses use GICS as a basis for portfolio construction, risk analysis or market screening. This means that it also makes sense for private investors to use this structure as a guide.
#7
Who decides which GICS sector a company is assigned to?
The allocation is made by the index providers MSCI and S&P Dow Jones on the basis of a company's main business segment. The decisive factor is the segment from which the company generates the majority of its sales or operating profit. Changes in the business model or strategic realignments can lead to a company being assigned to a different industry or even a different sector.
#8
What is meant by the GICS sector "Materials"?

The GICS "Materials" sector comprises companies that are active in the production, processing or refinement of raw materials. This includes industries such as chemicals, building materials, paper & forest products and the entire metallurgical and mining industry. The sector is highly cyclical and is particularly sensitive to economic fluctuations and changes in global demand.

#9
Which companies typically belong to the Materials sector?
Typical representatives are international groups from the areas of chemicals production (e.g. BASF), precious metal mining (e.g. Barrick Gold), building materials production (e.g. Heidelberg Materials) or industrial gases (e.g. Linde). The shares of these companies are often heavily dependent on commodity prices and play a central role in industrial value chains.
#10
Where does the company news on this page come from?
The news is based on verified and publicly available sources such as BusinessWire, GlobeNewswire, PR Newswire, EQS, Newsfile, ACCESSNewswire and other NewsWire services. These platforms are used by listed companies to publish mandatory ad hoc announcements, financial reports or strategic developments. All content is prepared in a structured manner and, if a corresponding categorization is possible, brought together in industry-specific clusters.
#11
How is the sector-specific mapping of messages carried out?
Categorization is based on structured metadata (e.g. ISIN, ticker, sector classification) and a combination of keyword analysis and GICS mapping. This ensures that all news is assigned to the correct sector and - if available - the correct sub-sector.
#12
Why is the materials sector particularly interesting for investors?
The Materials sector is closely linked to global industrial production and offers both cyclical growth opportunities and hedging opportunities against inflation and raw material shortages. In addition, many companies in this sector play a key role in future topics such as electromobility, the energy transition and sustainable building materials.
#13
What distinguishes this project from traditional financial information portals?
In contrast to generic portals, this project focuses exclusively and specifically on a particular sector. The advantage for interested investors: Sector-specific information, news, market movements and company profiles can be filtered and analyzed in a more targeted manner. This enables more in-depth research and greater relevance for thematic investment decisions.
#14
Are smaller companies also represented here or only large corporations?
The newsfeed takes into account both large caps and mid and small caps. As a clear mapping criterion is required in order to enable the most precise possible allocation to a cluster, the ISIN of the listed company is generally used for this purpose, provided that this can be made available or mapped via corresponding newsfeed parameters.
#15
How up-to-date are the displayed messages?
The content is updated regularly. The publication follows the publications of the information source, the NewsWire feeds of the underlying distributors. Incoming reports are automatically processed, classified and displayed on the page. Timestamps and source information ensure maximum transparency.
#16
Can I also filter the news by sub-sector?
Yes, this is a central feature of the site. Within a main sector, you can filter specifically for sub-sectors such as "Metals & Mining". For particularly popular industries or developments within a meta-sector, it is possible to deviate from standard clusters. Special categories with particular information value enable thematic analyses to be carried out even more precisely.
#17
Are there plans to process other metasectors in a similar way?
Yes, this financial information portal is part of an extensive project in which separate information portals are being created for all the main sectors. The aim is to provide investors with a systematic, sector-based research tool - regardless of index affiliation or provider perspective.
#18
Why do companies publish announcements via NewsWire services at all?
NewsWire services such as BusinessWire or PR Newswire fulfill a regulatory function: they enable companies to publish price-sensitive information publicly and without discrimination. In many countries, the use of such services is a prerequisite for fulfilling publication obligations under capital market law. They also enable companies to reach the media, analysts and investors in a targeted manner.
#19
Can private or inactive companies also appear in such notifications?
Generally not. The platform focuses exclusively on listed companies whose disclosures are based on regulatory requirements or corporate strategy measures. Although private or unlisted companies occasionally publish announcements, these are not systematically processed or classified here.
#20
What happens when a company changes its business model - does its sector classification also change?
Yes, as a rule - but not automatically. The responsible classification institutes (e.g. MSCI and S&P for GICS) regularly check the relevance and consistency of the classifications. If there is a significant change in a company's sales or profit profile, it may be reclassified to a different industry or even a different sector. This usually takes place after fixed review cycles or upon request.
#21
How is it ensured that a company is correctly categorized if it is active in several business areas?
The categorization is based on the dominant sales segment. If a company is active in several sectors but generates 70% of its turnover with chemical products, for example, it is assigned to the GICS sector "Materials" - even if it also has activities in the energy or transportation sector. In borderline cases, additional qualitative assessment criteria apply.
#22
Are there any legal risks in the further use of the displayed content?
The content comes from public sources, but is partially subject to copyright protection - particularly with regard to text structure and layout. The excerpts and links provided on this portal are made within the scope of permitted use (e.g. right to quote or editorial processing). However, commercial use by third parties is not permitted without the express permission of the original providers.
#23
Who can I contact if I have general questions or legal concerns?
A central contact point is available for general inquiries, information on company recordings, compliance issues or copyright-relevant aspects. In rare cases, for example in the case of erroneously published information or justified requests for deletion, a review and, if necessary, removal from the public feed can take place. Please only use the official contact option in the legal notice or at the bottom of the page.
#24
Is advertising or third-party content also displayed on the portal?
Yes, in defined areas the portal can display advertising content or product-specific information from third parties - for example on sector-related financial services, research offers or trading platforms. This content is clearly marked as advertising or partner information and is separate from the editorial or automatically processed company news.
#26
Can I give feedback on the platform or submit suggestions?
Absolutely - feedback is expressly welcome. The platform is an open information service that is continuously being developed. Comments on functionality, data quality, usability or thematic extensions help to optimize the service for the benefit of users. You can submit your suggestions informally via the contact page or special feedback forms.
#27
I am an information provider - can I cooperate with the portal?
Yes, the portal is open to content-related, technical or editorial cooperation, provided that this contributes to the quality, relevance or dissemination of the offering. If you offer content, interfaces or services that could be useful in the context of stock market-related information, we would be pleased to hear from you. The platform offers flexible integration options and a professional environment for quality-assured content.
#28
Can the platform technology also be used for other applications or partners?
Yes, the platform is based on a modular, scalable infrastructure that can be adapted to different information contexts and industry models. Technical components such as data aggregation, structuring logic, classification mechanisms and semantic filters can also be made available for external projects or individual applications on request. Please contact us for cooperation or license models.
#29
Can the underlying company data also be licensed or reused?
Structured access to selected master data of listed companies - such as GICS mapping, ISIN mapping, news feeds or metadata filters - is generally possible. The offer is aimed in particular at information service providers, research platforms or data-driven financial applications. Data can be provided via defined interfaces (e.g. API) or exportable formats, depending on the intended use and license framework.
#30
What forms of cooperation with external partners are conceivable?
Basically open. Possible forms of cooperation range from technical integrations and shared data models to content syndication or white label solutions. Partnerships with institutions that are looking for access to quality-assured data, dynamically structured news or sector-specific analyses - for example in the FinTech, media or research environment - are particularly interesting. We look forward to hearing from business development or product management departments.
#31
Why does this portal differ technically and conceptually from other information offerings?
Because no one from outside the industry is trying to understand the financial market here - but because the know-how comes from the heart of the financial world. The technical platform was developed by a team that combines in-depth market knowledge with innovative system design. The result: information architecture with real relevance, not shop window technology.
#32
What makes the technical solution particularly interesting for operators of their own financial portals?
In addition to high adaptability, the platform impresses with its modular structure and the consistent implementation of industry-specific logic - from GICS mapping to metadata filtering. For providers who operate their own information portals, sector-specific data structures, news feeds or visualizations can be quickly integrated on this basis - either as a white label, API module or embedded solution.
#33
Why can a collaboration go beyond traditional development services?
Because we don't just program, we think: The technological implementation is based on a deep understanding of market cycles, regulations, data formats and investor needs. Anyone who cooperates with this platform benefits from a sparring partner at eye level - both technically and professionally. This creates added value that goes far beyond pure IT expertise.
#34
Note on copyright and the processing of original content
The corporate news presented on this information portal is based on publicly accessible sources such as BusinessWire, GlobeNewswire, PR Newswire or comparable news services. The content is processed as part of an automated or editorially supported structuring process without changing, shortening or reinterpreting the content of the original information. This is so-called "as is" information, the form and content of which corresponds to the originally published announcement. The rights to the original texts remain unrestrictedly with the respective publishers or copyright holders. This portal merely assumes a structural categorization and allocation within the framework of a news-journalistic offer. Independent commercial reuse, systematic reproduction or other use of the content by third parties is only permitted within the framework of the statutory provisions or with the consent of the copyright holder.
About GICS Health
GICS Health is part of the GICS Eleven information portfolio, which focuses primarily on information from listed companies in the health sector. The sector classification serves as a guide to navigate quickly and conveniently through the latest industry-specific news. Individual peer group clusters complement the news offering.
About GICS Eleven

GICS Eleven (G11, GICS11) bundles topic-specific content and enables quick access to relevant information thanks to its gate function. The project is largely based on the Global Industry Classification Standard (GICS®), which was developed by MSCI and Standard & Poor's and enables a breakdown into sectors. GICS® consists of 11 sectors, 24 industry branches, 69 industries and 158 sub-industries.

GICS® is a registered trademark of MSCI Inc. and S&P Dow Jones Indices.

Member of 3R/RSQ Network
Digital Content
Network Alliance
Transparency - Reliability - Credibility
Information regarding Product Information
Tuesday, 20.01.2026, Calendar Week 04, 20th day of the year, 345 days remaining until EoY.